To determine the incidence, prevalence, and outcome of systemic lupus erythematosus (SLE) in a weli delineated black population in the Caribbean basin data were collected on the disease course of ali patients with definite SLE seen during a 10 year period (1980-9) using three different sources of information (hospital records, private practice records, and death certificates). Ninety four patients were identified giving an average annual incidence rate of 4-6/100 000 (95% confidence interval (CI) 0-4 to 8-8), which showed little variation during the study period. Twenty five patients (27%) died during the study period, giving a point prevalence of 47/100 000 (CI 34-1 to 51-1) in 1990. In women aged 15-44 years the annual incidence (12/100 000; CI 5-3 to 18.9) was highest, whereas in women aged 44-65 years the 1990 point prevalence rate (one in 526; CI 469 to 625) was highest. Annual mortality was 1-7/100 000 (CI -0-8 to 4-2) with a female to male ratio of 5-3. Renal disease was the most common complication, occurring in 73 (78%) patients. Thus the transatlantic movement from an area with a (presumably) low prevalence of SLE (Central Africa) has been accompanied by an increase in the prevalence of SLE in the black population of Curaqao, indicating that environmental factors may prevail over genetic factors in the expression of this disease.
Reports on the incidence and prevalence of systemic lupus erythematosus (SLE) show a considerable variation between countries and sometimes within one country.`-9 Although a considerable part of these variations is probably due to differences in patient selection, environmental and genetic factors are also believed to influence disease expression.' 4 Ethnicity is considered to be one of the predominant determinants, as black subjects in the USA have a threefold increased incidence of SLE compared with white subjects,3 5 whereas in Chinese subjects the disease is even more common.6 7 On the other hand, SLE is still considered to be a rare disease (although sound epidemiological data from the area are not available) in Central Africa, which is the original homeland of many black Americans.8 At the same time as the black population was introduced into the USA, the island of Curaqao in the Caribbean basin was also populated by black people from Central Africa. They now make up more than 95% of the population on the island. This study reports the epidemiology of SLE in this well delineated black population.
Patients and methods

PATIENTS
The island of Curacao is an autonomous part of the Dutch Kingdom, located 60 km off the coast of Venezuela with a (sub) tropical climate. Its population is estimated to be 146 500, of which less than 5% are white and which has a migratory rate of about 1%.'°There is one major 450 bed teaching hospital which serves the whole island. To ensure a maximum degree of completeness, information on all patients with SLE seen during the period 1980-9 was gathered from three different sources. Firstly, all medical records of patients discharged from the hospital during the study period with a diagnosis of SLE (ICD code 710.0) were reviewed; with this method 85 patients were identified. Secondly, all specialists in internal medicine (six) and dermatology (two) (there is no rheumatologist on the island) were asked in 1989 to provide information on all patients with lupus who had been in their care during that period; although most of the consultants did not keep an official diagnostic index, this provided another eight patients not identified by the hospital registry. Thirdly, all death certificates in the Public Health Department from that period containing a diagnosis of SLE were reviewed and medical records of the patients were retrieved; this provided one patient not identified by either of the other two sources.
METHODS
All patient records were reviewed by one investigator using a predefined data extraction form. Only patients fulfilling four or more American Rheumatism Association (ARA) criteria for the classification of SLE" were entered into the study. Information was gathered on demographic features, (cumulative) ARA criteria, initial disease activity at the time of diagnosis using the validated SLEDAI score,'2 and subsequent disease course. Period prevalence rates were calculated using all patients with definite SLE seen during the study period, whereas incidence rates were calculated using only true incident cases-that is, those diagnosed during the 10 year study period. The time at which a patient fulfilled at least four ARA criteria was chosen as the time of diagnosis. For calculations of age specific rates we used the age distribution classes as given in the report by Nossent Siegel et al. Figure 1 shows the course of prevalence rates for the study period. Analysis of age specific prevalence rates by gender at the end of the study period revealed a maximum prevalence rate of 186 6/100 000 (or one in 526) in women aged 45-64 (table 3) . Sixty eight true incident cases were identified during the 10 year study, giving a mean annual incidence rate of 4-6/100 000 at risk (CI 0-4 to 8-8). Annual incidence rates for the whole study period are also shown in figure 1 and show a relatively const -t level of newly diagnosed cases over the 10 y-r period. Table 4 shows the age specific incidence rates by gender during that period. Considerable variations were found, with the lowest rate (0-57/100 000) for men aged 15-44 years and the highest rate (12-1/100 000) in women in the same age group.
MORTALITY
Twenty five patients (27%) died during study period. There was no difference in the the 'Average annual rate per 100 000 subjects during study period; C'I denotes 95%, confidence interval.
proportion of deaths in true incident cases compared with patients diagnosed before 1980. The mean (SD) age at death was 42-0 (18-1) years, whereas the median (range) disease duration at death was 80-5 (9-214) months. Mean (SD) disease activity (by SLEDAI score) at the time of death was 14 4 (9 1; median 13-5). can be superseded by environmental factors as a major determinant for the expression of SLE. Also, the annual incidence rate in this black population (4-6/100 000) is almost identical to that found in a study in south Sweden within a study group with a entirely different genotypic make up,'5 although it is lower than that in a group of black subjects in Baltimore. 
explain the low prevalence of SLE in Africa,'6 but this finding has not been expanded. Others assume that various factors (toxic, psychological) in the Western world may predispose for the development of SLE,4 making SLE a disease of prosperity. Siegel, in his landmark study, found a lower prevalence of lupus in black and white subjects in rural areas compared with those in a large city, but definitive proof is lacking. The possibility of not determining all subjects affected was a major concern in this study, as the most critical part was the non-availability of diagnostic indices from the cooperating consultants, who thus had to rely on memory to identify patients. As SLE is a chronic disease in which exacerbations may occur at any time in the disease course, most patients with lupus remain under prolonged control (although the frequency of visits may vary) and, as the island population has a low migratory rate,'0 it seems unlikely that the number of patients who may have been missed by the methods used (because they were discharged or had left the island) would have significantly altered the given rates. Also, Petri et al 17 have found an average admission frequency of 4-4 over a five year period for patients with lupus in an inner city population, whereas Pistiner et al showed that more than half of their new (private) patients with lupus in the last decade needed at least one admission.'8 Thus the admission rate for patients with SLE in the first years of their disease is high and socioeconomic factors seem to influence this rate. As the per capita annual income in Curaqao is about US$5000,10 the high frequency of admitted patients in this study is not remarkable and lessens the probability of cases being under estimated. The good overlap of patient identification (only 10% of patients identified by one source only) also supports this view.
The occurrence of specific clinical manifestations (initially and overall) of SLE in our patients and the sex distribution was similar to that in reports from Jamaica,'4 Sweden,'5 the USA,'8 '9 and The Netherlands.20 As this study was based on patient record findings, however, it is conceivable that skin lesions (erythema may be hard to distinguish in black patients) and mouth ulcers may have been underestimated as these diagnoses are easily missed during routine investigations. Lupus nephritis was a common complication, present at diagnosis in 48% and finally in 78% of our patients. As histological confirmation was not always obtained these results may be an overestimation, but it has been reported that black patients with SLE tend to have more common and more serious renal disease. 
